LB Pharmaceuticals Inc. has granted equity awards to two new executives, Ellen Rose, Senior Vice President of Corporate Affairs, and Lindsay Beaupre, Senior Vice President of People and Culture. Ellen Rose received options to purchase 100,000 shares of common stock, while Lindsay Beaupre received options for 75,000 shares. The options have a ten-year term and an exercise price of $20.73 per share, reflecting the closing price on the grant date. The options vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting monthly over the following three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9623270) on January 12, 2026, and is solely responsible for the information contained therein.